TYTatsuya Yamamoto

Tatsuya Yamamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tatsuya Yamamoto has a total of 224 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neural Correlates of Apathy in Multiple System Atrophy: A Clinical and Perfusion Imaging Study

    by Yuki Nakagawa, Atsuhiko Sugiyama, Yoshikazu Nakano, Hajime Yokota, Shigeki Hirano, Masahiro Namiki, Tatsuya Yamamoto, Yoshitaka Yamanaka, Shoichi Ito, Masahiro Mori

    Background: Apathy is a frequent nonmotor symptom of multiple system atrophy (MSA) that worsens quality of life. Although frontostriatal dysfunction has been implicated in apathy, its neural basis in MSA remains insufficiently characterized. Objectives: To identify the neural substrates of apathy associated with MSA‐specific neurodegenerative processes. Methods: This retrospective cross‐sectional study included 76 patients with cognitively preserved clinically established/probable MSA who underwent clinical and neuropsychological assessments, including the Apathy Scale and a separate depression measure, magnetic resonance imaging, and cerebral blood flow single‐photon emission computed tomography. Clinical variables, gray matter volume, and voxel‐wise perfusion were compared between apathy and non‐apathy groups. Multivariate logistic regression was used to analyze the independent association of the significant perfusion cluster with apathy, and seed‐based covariance analysis was used to explore network alterations. Results: Apathy was present in 55.3% of patients and did not differ between motor subtypes. Compared with the non‐apathy group, the apathy group showed lower visuospatial scores and frequency of neurogenic orthostatic hypotension, similar depression scores and gray matter volume, and reduced perfusion in the medial prefrontal cortex on voxel‐wise perfusion analysis. These findings remained independently associated with apathy after adjustment for clinical variables. Seed‐based covariance analysis suggested reduced positive covariance between the medial prefrontal cortex and cerebellar regions, predominantly in the posterior lobe. Conclusions: Apathy was common in MSA even with relatively preserved global cognition and distinct from depression. In addition to medial frontostriatal dysfunction, exploratory findings suggested that mechanisms related to cerebellar cognitive affective syndrome may contribute to its pathophysiology.

  • Validation of orthostatic hypotension in MDS diagnostic criteria for multiple system atrophy

    by Satoko Yoshizaki, Yoshitaka Yamanaka, Tatsuya Yamamoto, Nobuyuki Araki, Atsuhiko Sugiyama, Shigeki Hirano, Satoshi Kuwabara

    Purpose: In 2022, the Movement Disorder Society (MDS) proposed revised diagnostic criteria for multiple system atrophy (MSA), defining neurogenic orthostatic hypotension (OH) as a reduction in systolic/diastolic blood pressure exceeding 20/10 mmHg. This study aimed to validate the sensitivity of the MDS OH criteria and to compare the extent and pattern of OH across synucleinopathies, including Parkinson disease (PD), dementia with Lewy bodies (DLB), and pure autonomic failure (PAF). Methods: The medical records of 451 patients were retrospectively reviewed, including those with clinically probable MSA (n=107), PD (n=223), DLB (n=89), and PAF (n=32). OH was assessed using both the MDS and Gilman criteria for probable MSA. Systolic blood pressure overshoot following head-up tilting was also evaluated. Results: Among patients with MSA, neurogenic OH was identified in 39.3% using the Gilman criteria and in 64.5% using the MDS criteria (p<0.001). OH based on the MDS criteria was also detected in PD (39.0%), DLB (67.4%), and PAF (87.5%). Systolic blood pressure overshoot was observed in patients with MSA (6.5%), PD (12.6%; p=0.097 versus MSA), DLB (21.3%; p=0.002), and PAF (28.1%; p<0.001). Conclusions: The MDS criteria more sensitively detect neurogenic OH in MSA compared with the Gilman criteria. Although OH is common across synucleinopathies, the lower frequency of systolic blood pressure overshoot in MSA may assist in its differentiation, potentially reflecting less prominent postganglionic autonomic impairment.

  • Open Access

    The examination of detrusor underactivity in multiple system atrophy

    by Tatsuya Yamamoto, Ryuji Sakakibara, Tomoyuki Uchiyama, Satoshi Kuwabara

    Aims: The urinary dysfunction in multiple system atrophy (MSA) is characterized by large post-void residuals (PVR) due to impaired bladder contractility. However, the evaluations of bladder contractility are not well validated in MSA. Because the bladder contractility index can be generally represented as Pdet Qmax (detrusor pressure at maximum urinary flow rate) + kQmax (maximum urinary flow rate), we aim to examine which “k” value is suitable for representing bladder contractility concerning its correlations to PVR and voided percentage (VOID%).Methods: We retrospectively reviewed 133 patients with MSA (74 males, 59 females, mean disease duration 3.2 years) who underwent an urodynamic study. We calculated bladder contractility using the formula PIPk = Pdet Qmax + kQmax by increasing the “k” value from 0.1 to 10 by increments of 0.1. We calculated the correlations between each PIPk (k = 0.1–10.0) and PVR and VOID%.Results: The correlational coefficients between PIPk and VOID% were larger than those between PIPk and PVR. The correlational coefficients between PIPk and VOID% reached a plateau level at a “k” value >5.0 in male patients, suggesting that currently used formulas such as Pdet Qmax + 5Qmax for males might be appropriate for male MSA patients. However, the correlational coefficients between PIPk and VOID% reached a plateau level in female patients when the “k” values were >6.0, which might overestimate bladder contractility in female patients.Conclusion: Although currently used formulas such as Pdet Qmax + 5Qmax might be appropriate for male MSA patients, formulas for female patients need further evaluation.


  • Open Access

    Differentiation between Parkinson’s Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle

    by Jiaqi Wang, Atsuhiko Sugiyama, Hajime Yokota, Shigeki Hirano, Tatsuya Yamamoto, Yoshitaka Yamanaka, Nobuyuki Araki, Shoichi Ito, Friedemann Paul, Satoshi Kuwabara

    Multiple system atrophy with predominant parkinsonism (MSA-P) can hardly be distinguished from Parkinson’s disease (PD) clinically in the early stages. This study investigated whether a standardized T1-weighted/T2-weighted ratio (sT1w/T2w ratio) can effectively detect degenerative changes in the middle cerebellar peduncle (MCP) associated with MSA-P and PD and evaluated its potential to distinguish between these two diseases. We included 35 patients with MSA-P, 32 patients with PD, and 17 controls. T1w and T2w scans were acquired using a 1.5-T MR system. The MCP sT1w/T2w ratio was analyzed via SPM12 using a region-of-interest approach in a normalized space. The diagnostic performance of the MCP sT1w/T2w ratio was compared between the MSA-P, PD, and controls. Patients with MSA-P had significantly lower MCP sT1w/T2w ratios than patients with PD and controls. Furthermore, MCP sT1w/T2w ratios were lower in patients with PD than in the controls. The MCP sT1w/T2w ratio showed excellent or good accuracy for differentiating MSA-P or PD from the control (area under the curve (AUC) = 0.919 and 0.814, respectively) and substantial power for differentiating MSA-P from PD (AUC = 0.724). Therefore, the MCP sT1w/T2w ratio is sensitive in detecting degenerative changes in the MCP associated with MSA-P and PD and is useful in distinguishing MSA-P from PD.


  • Parkinson's disease and nocturnal polyuria

    by Ryuji Sakakibara, Ayami Shimizu, Osamu Takahashi, Tsuyoshi Ogata, Setsu Sawai, Tomoyuki Uchiyama, Tatsuya Yamamoto

    Background: The question of whether Parkinson's disease (PD) patients have nocturnal polyuria (NP) has not yet been fully answered.Objectives: To determine whether NP was present in PD patients and if so, what its relevant factors were.Methods: This was a retrospective analysis. We had 36 consecutive referred PD patients: age, 71.5 years (range, 54–83 years); 24 men, 12 women; mean disease duration, 2.5 years (1.0–4.5 years); Hoehn and Yahr motor scale, 3.0 (2.0–3.5); all ambulatory; all on treatment. All the PD patients completed a lower urinary tract symptom (LUTS questionnaire) and a bladder diary, and underwent urodynamics testing.Results: NP was identified in 56% of patients. NP was more common in patients with nocturia (p < 0.05), and in patients with urodynamic detrusor overactivity (p < 0.01). There was no relation between NP and gender, age, PD medications, blood pressure, or comorbid diabetes.Conclusions: A total of 56% of PD patients had NP, which had a close relation with detrusor overactivity (p < 0.01). These findings suggest that in PD, the loss of dopaminergic neurons leads to NP (hypothalamic circuit) and detrusor overactivity (nigrostriatal circuit).


  • Open Access

    Editorial: Autonomic dysfunction in multiple system atrophy

    by Tatsuya Yamamoto, Maria Teresa Pellecchia, Ryuji Sakakibara

    Editorial: Autonomic dysfunction in multiple system atrophy


  • Open Access

    DRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson’s Disease: Voxel-Based Morphometry

    by Kenji Ohira, Hajime Yokota, Shigeki Hirano, Motoi Nishimura, Hiroki Mukai, Takuro Horikoshi, Setsu Sawai, Yoshitaka Yamanaka, Tatsuya Yamamoto, Shingo Kakeda, et al.

    Taq1A polymorphism is a DRD2 gene variant located in an exon of the ANKK1 gene and has an important role in the brain’s dopaminergic functions. Some studies have indicated that A1 carriers have an increased risk of developing Parkinson’s disease (PD) and show poorer clinical performance than A2 homo carriers. Previous studies have suggested that A1 carriers had fewer dopamine D2 receptors in the caudate and increased cortical activity as a compensatory mechanism. However, there is little information about morphological changes associated with this polymorphism in patients with PD. The study’s aim was to investigate the relationship between brain volume and Taq1A polymorphism in PD using voxel-based morphometry (VBM). Based on Taq1A polymorphism, 103 patients with PD were divided into two groups: A1 carriers (A1/A1 and A1/A2) and A2 homo carriers (A2/A2). The volume of the left prefrontal cortex (PFC) was significantly decreased in A2 homo carriers compared to A1 carriers. This finding supports the association between Taq1A polymorphism and brain volume in PD and may explain the compensation of cortical function in A1 carriers with PD.